Go Pro
→ The $15 Gold Fund That Pays Up to $1,152/Month (From Investors Alley) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
The Allstate Corporation stock logo
ALL
Allstate
$263.63
+1.7%		$256.51
$188.08
▼
$277.22
$65.58B0.151.68 million shs1.33 million shs
Rio2 Limited stock logo
ATM
Rio2
C$0.68
+1.5%		C$0.68
C$0.57
▼
C$0.86
C$57.62MN/A114,654 shs15,000 shs
Emerald Health Therapeutics, Inc. stock logo
EMH
Emerald Health Therapeutics
C$0.26
-3.8%		C$0.26
C$0.15
▼
C$0.53
C$52.28MN/A644,760 shs384,329 shs
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
The Allstate Corporation stock logo
ALL
Allstate
+1.59%+2.48%+0.44%+19.30%+29.00%
Rio2 Limited stock logo
ATM
Rio2
0.00%0.00%0.00%0.00%0.00%
Emerald Health Therapeutics, Inc. stock logo
EMH
Emerald Health Therapeutics
0.00%0.00%0.00%0.00%0.00%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
The Allstate Corporation stock logo
ALL
Allstate
$263.63
+1.7%		$256.51
$188.08
▼
$277.22
$65.58B0.151.68 million shs1.33 million shs
Rio2 Limited stock logo
ATM
Rio2
C$0.68
+1.5%		C$0.68
C$0.57
▼
C$0.86
C$57.62MN/A114,654 shs15,000 shs
Emerald Health Therapeutics, Inc. stock logo
EMH
Emerald Health Therapeutics
C$0.26
-3.8%		C$0.26
C$0.15
▼
C$0.53
C$52.28MN/A644,760 shs384,329 shs
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
The Allstate Corporation stock logo
ALL
Allstate
+1.59%+2.48%+0.44%+19.30%+29.00%
Rio2 Limited stock logo
ATM
Rio2
0.00%0.00%0.00%0.00%0.00%
Emerald Health Therapeutics, Inc. stock logo
EMH
Emerald Health Therapeutics
0.00%0.00%0.00%0.00%0.00%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
The Allstate Corporation stock logo
ALL
Allstate
2.41
Hold$263.900.10% Upside
Rio2 Limited stock logo
ATM
Rio2
0.00
N/AN/AN/A
Emerald Health Therapeutics, Inc. stock logo
EMH
Emerald Health Therapeutics
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest EMH, ATM, ALL, and MNRG Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/28/2026
The Allstate Corporation stock logo
ALL
Allstate
Argus logo
Argus
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price Target$238.00
8/28/2026
The Allstate Corporation stock logo
ALL
Allstate
Argus logo
Argus
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy ➝ Hold
8/25/2026
The Allstate Corporation stock logo
ALL
Allstate
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeBuy (A) ➝ Buy (A-)
8/20/2026
The Allstate Corporation stock logo
ALL
Allstate
Keefe, Bruyette & Woods logo
Keefe, Bruyette & Woods
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingMarket Perform ➝ Underperform$255.00 ➝ $250.00
8/19/2026
The Allstate Corporation stock logo
ALL
Allstate
Keefe, Bruyette & Woods logo
Keefe, Bruyette & Woods
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeHold ➝ Moderate Sell
8/17/2026
The Allstate Corporation stock logo
ALL
Allstate
Zacks Research logo
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHold ➝ Strong-Buy
8/11/2026
The Allstate Corporation stock logo
ALL
Allstate
Morgan Stanley logo
Morgan Stanley
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price Target$265.00
8/11/2026
The Allstate Corporation stock logo
ALL
Allstate
Raymond James Financial, Inc. logo
Raymond James Financial
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingStrong-Buy$315.00
8/11/2026
The Allstate Corporation stock logo
ALL
Allstate
Citigroup Inc. logo
Citigroup
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeNeutral ➝ Sell$226.00 ➝ $240.00
8/11/2026
The Allstate Corporation stock logo
ALL
Allstate
JPMorgan Chase & Co. logo
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOverweight$282.00 ➝ $292.00
(Data available from 9/4/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
The Allstate Corporation stock logo
ALL
Allstate
$67.69B0.98$38.77 per share6.80$125.28 per share2.10
Rio2 Limited stock logo
ATM
Rio2
N/AN/AN/AN/AN/AN/A
Emerald Health Therapeutics, Inc. stock logo
EMH
Emerald Health Therapeutics
C$13.02M4.02C$0.33 per share0.78C$0.40 per share0.64
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
The Allstate Corporation stock logo
ALL
Allstate
$10.28B$50.085.269.490.6018.97%41.64%9.82%11/4/2026 (Estimated)
Rio2 Limited stock logo
ATM
Rio2
N/AN/AN/AN/AN/AN/AN/AN/AN/A
Emerald Health Therapeutics, Inc. stock logo
EMH
Emerald Health Therapeutics
N/A-C$0.70N/AN/AN/AN/AN/AN/AN/A

Latest EMH, ATM, ALL, and MNRG Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/5/2026Q2 2026
The Allstate Corporation stock logo
ALL
Allstate
$6.06$8.99+$2.93$12.51$15.46 billion$18.60 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
The Allstate Corporation stock logo
ALL
Allstate
$4.321.64%+13.12%8.63%15 Years
Rio2 Limited stock logo
ATM
Rio2
N/AN/AN/AN/AN/A
Emerald Health Therapeutics, Inc. stock logo
EMH
Emerald Health Therapeutics
N/AN/AN/AN/AN/A

Latest EMH, ATM, ALL, and MNRG Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
7/8/2026
The Allstate Corporation stock logo
ALL
Allstate
quarterly$1.081.67%8/31/20268/31/202610/1/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
The Allstate Corporation stock logo
ALL
Allstate
0.24
0.36
0.36
Rio2 Limited stock logo
ATM
Rio2
N/AN/AN/A
Emerald Health Therapeutics, Inc. stock logo
EMH
Emerald Health Therapeutics
35.45
2.97
2.61

Institutional Ownership

CompanyInstitutional Ownership
The Allstate Corporation stock logo
ALL
Allstate
76.47%
Rio2 Limited stock logo
ATM
Rio2
N/A
Emerald Health Therapeutics, Inc. stock logo
EMH
Emerald Health Therapeutics
N/A

Insider Ownership

CompanyInsider Ownership
The Allstate Corporation stock logo
ALL
Allstate
1.55%
Rio2 Limited stock logo
ATM
Rio2
N/A
Emerald Health Therapeutics, Inc. stock logo
EMH
Emerald Health Therapeutics
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
The Allstate Corporation stock logo
ALL
Allstate
53,300252.86 million248.94 millionOptionable
Rio2 Limited stock logo
ATM
Rio2
N/A84.74 millionN/ANot Optionable
Emerald Health Therapeutics, Inc. stock logo
EMH
Emerald Health Therapeutics
161205.03 millionN/ANot Optionable

Recent News About These Companies

Women’s Health Therapeutics Market Size to Reach USD 61.6 Billion by 2032, Driven by Rising Awareness & Technological Advancements - SNS Insider
October 17, 2024  |  finance.yahoo.comhttps://finance.yahoo.com/news/women-health-therapeutics-market-size-131000318.html
Emerald Princess
May 24, 2024  |  travel.usnews.comhttps://travel.usnews.com/cruises/princess-cruises-298/emerald-princess-373/passenger-reviews/
University Hospitals Elyria Medical Center
September 22, 2023  |  health.usnews.comhttps://health.usnews.com/best-hospitals/area/oh/emh-elyria-medical-center-6411290/doctors/gastroenterologists
Digital Therapeutics: Next wave in managing chronic medical conditions
September 13, 2023  |  health.economictimes.indiatimes.comhttps://health.economictimes.indiatimes.com/news/health-it/digital-therapeutics-next-wave-in-managing-chronic-medical-conditions/103575858
The Digital Therapeutics Market Is Gangbusters
August 29, 2023  |  mddionline.comM
Digital Therapeutics (DTx) For Mental Health Market is Booming and Expected to Grow at a CAGR of 27.42% to 2031 | InsightAce Study
July 30, 2023  |  finance.yahoo.comhttps://finance.yahoo.com/news/digital-therapeutics-dtx-mental-health-114300876.html
Emerald Isle’s Lee Avenue to close again soon as culvert project restarts
July 15, 2023  |  carolinacoastonline.comC
Efficient Market Hypothesis (EMH): Definition and Critique
July 12, 2023  |  investopedia.comhttps://www.investopedia.com/terms/e/efficientmarkethypothesis.asp
Revolutionizing mental health treatment: Vistagen Therapeutics' nasal spray solution
June 20, 2023  |  finance.yahoo.comhttps://finance.yahoo.com/news/revolutionizing-mental-health-treatment-vistagen-163646319.html
Menarini Group Shares New Analysis from EMERALD Clinical Study of ORSERDU® (Elacestrant) in Metastatic Breast Cancer at ASCO 2023
May 29, 2023  |  thaipr.netT
Emerald Care Center Tulsa
May 4, 2023  |  health.usnews.comhttps://health.usnews.com/best-nursing-homes/area/ok/emerald-care-center-tulsa-375094
Emerald Reeg
April 25, 2023  |  health.usnews.comhttps://health.usnews.com/physician-assistants/emerald-reeg-2976188
Emerald Expositions GAAP EPS of $0.06, revenue of $93.6M
March 14, 2023  |  msn.comhttps://www.msn.com/en-us/money/companies/emerald-expositions-gaap-eps-of-006-revenue-of-936m/ar-AA18Bs7k
Tahoe's Emerald Bay freezes over for first time in decades amid atmospheric river
March 13, 2023  |  sfgate.comhttps://www.sfgate.com/renotahoe/article/atmospheric-river-freezes-tahoe-emerald-bay-17832444.php
Visus Therapeutics to Attend TD Cowen’s 43rd Annual Health Care Conference
March 4, 2023  |  venturebeat.comV
Emerald community raising money for local dialysis services after political campaigns fail
February 24, 2023  |  abc.net.auA
New Digital Therapeutics Company Takes a 'Swing' at Fibromyalgia
February 22, 2023  |  mddionline.comM
Emerald Asset Management PA, LLC 30th Annual Emerald Groundhog Day Investment Forum Opens Amid a Stormy 2023 Investment Year
January 14, 2023  |  finance.yahoo.comhttps://finance.yahoo.com/news/emerald-asset-management-pa-llc-184500157.html
Emerald Health Therapeutics Inc (TBD.BE)
January 4, 2023  |  finance.yahoo.comhttps://finance.yahoo.com/quote/TBD.BE/history/
Emerald Health Therapeutics Announces Revocation of Management Cease Trade Order
July 12, 2022  |  finance.yahoo.comhttps://finance.yahoo.com/news/emerald-health-therapeutics-announces-revocation-110000669.html

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Laboratory with a cryogenic quantum processor chamber, optical laser setup on a table, and data monitors displaying waveforms.
Quantum Earnings Week: Winners and Losers Are Finally Emerging
By Nathan Reiff | August 8, 2026
A quantum computing processor glows inside a gold-plated dilution refrigerator in a research laboratory.
The Quantum Race Is Heating Up—And 2 Small Players Stand Out
By Nathan Reiff | August 17, 2026
NVIDIA logo displayed on a computer chip surrounded by illuminated green circuit board traces.
NVIDIA’s Rally Sets Up a Bigger Test Ahead of Earnings
By Thomas Hughes | August 11, 2026
The Metals Company logo displayed over an image of polymetallic nodules on the seafloor with sea stars.
The Metals Company’s Big Bet Now Comes Down to a License
By Thomas Hughes | August 16, 2026
Trading floor with digital stock displays and workstations, overlaid with the text "S&P 500".
5 Reasons the S&P 500 Could Keep Rallying Through Year-End
By Thomas Hughes | August 20, 2026
Allstate stock logo

Allstate NYSE:ALL

$263.63 +4.29 (+1.65%)
Closing price 09/3/2026 03:58 PM Eastern
Extended Trading
$263.33 -0.30 (-0.11%)
As of 04:01 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments. The Allstate Protection segment offers private passenger auto and homeowners insurance; other personal lines products; and commercial lines products through agents, contact centers, and online. The Protection Services segment provides consumer product protection; protection and insurance products, including vehicle service contracts, guaranteed asset protection, road hazard tire and wheel, and paintless dent repair protection; and roadside assistance, device and mobile data collection services, and analytic solutions using automotive telematics information, as well as identity theft protection and remediation services. This segment also offers its products under various brands, including Allstate Protection Plans, Allstate Dealer Services, Allstate Roadside, Arity, Avail, and Allstate Identity Protection. The Allstate Health and Benefits segment provides life, accident, critical illness, short-term disability, and other health insurance products; stop-loss and fully insured group health products to employers; and short-term medical and medicare supplement insurance to individuals. The Run-off Property-Liability segment offers property and casualty insurance coverage that primarily relates to policies written during the 1960s through the mid-1980s. The Corporate and Other segment provides debt services, as well as non-insurance operations. It sells its products through agents, independent agents, call and contact centers, retailers, direct to consumer, wholesale partners, and affinity groups, as well as through online and mobile applications. The Allstate Corporation was founded in 1931 and is headquartered in Northbrook, Illinois.

Rio2 stock logo

Rio2 CVE:ATM

C$0.68 +0.01 (+1.49%)
As of 07/26/2018

Atacama Pacific Gold Corporation, an exploration stage company, engages in the acquisition, exploration, and development of gold properties in Chile. The company principally holds a 100% interest in the Cerro Maricunga gold project located in Region III northeast of the city of Copiapo. Atacama Pacific Gold Corporation was incorporated in 2008 and is headquartered in Toronto, Canada.

Emerald Health Therapeutics stock logo

Emerald Health Therapeutics CVE:EMH

C$0.26 -0.01 (-3.77%)
As of 04/26/2021

Emerald Health Therapeutics, Inc., together with its subsidiaries, produces and sells medical cannabis for medical purpose in Canada. The company is also involved in developing natural health products. It offers dried cannabis strains, pre-rolls, and cannabis oil products to its medical patients. The company was formerly known as T-Bird Pharma Inc. and changed its name to Emerald Health Therapeutics, Inc. in June 2015. Emerald Health Therapeutics, Inc. is headquartered in Vancouver, Canada.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas